Trump Lights Up the Cannabis Market With Plans for Reclassification

The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like heroin and LSD — cannabis is deemed to have no accepted medical use and high abuse potential. This status blocks research, interstate commerce, and access to basic banking services for operators. Meanwhile, 38 states have legalized medical marijuana, and 24 allow recreational use, creat ...